Peripheral arterial disease in HIV patients older than 50 years of age

AIDS Research and Human Retroviruses

Volumn 24, Issue 8, 2008, Pages 1043-1046

  Palacios, Rosario ^a   Alonso, Inmaculada ^b   Hidalgo, Ana ^a   Aguilar, Isabel ^a   Sánchez, Miguel A ^a   Valdivielso, Pedro ^a   González Santos, Pedro ^a   Santos, Jesús ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Centro de Prevencion de Riesgos Laborales   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK; SPAIN;

EID: 50249108415     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0001     Document Type: Article

References (28)

1. Santos J, Palacios R, González M, et al.: Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study). Int J STD AIDS 2005;16:677-680.
2. Friis-Møller N, Reiss P, Sabin CA, et al., and The D.A.D. Study Group: Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-1735.
3. Jericó C, Knobel H, Sorli ML, et al.: Prevalence of cardiovascular risk factors in HIV-infected patients. Rev Clin Esp 2006;206:556-559.
4. Grinspoon S and Carr A: Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005;352:48-62.
5. Kamin DS and Geinspoon SK: Cardiovascular disease in HIV-positive patients. AIDS 2005;19:641-652.
6. Newman AB, Shemanski L, Manolio TA, et al.: Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:538-545.
7. Tsai AW, Folsom AR, Rosamond WD, et al.: Ankle-brachial index and 7-year ischemic stroke incidence. The ARIC Study. Stroke 2001;32:1721-1724.
8. Resnick HE, Lindsay RS, McDermott MM, et al.: Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality. The Strong Heart Disease. Circulation 2004;109:733-739.
9. Wild SH, Byrne CD, Smith FB, et al.: Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care 2006;29:637-642.
10. Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-1621.
11. Hirsch AT, Haskal ZJ, Hertzer NR, et al.: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006:113:e463-e654.
12. Mostaza JN, Vicente I, Cairols M, et al.: Ankle brachial index and cardiovascular risk. Med Clin 2003;121:68-73.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998;21:5S-19S.
15. Joint National Committee: The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
16. Fowkes FG: The measurement of atherosclerotic peripheral artery disease in epidemiological surveys. Int J Epidemiol 1988;17:248-254.
17. Wattanakit K, Folsom AR, Duprez DA, et al.: Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2007;190:459-464.
18. Weatherley BD, Nelson JJ, Heiss G, et al.: The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, 1987-2001. BMC Cardiovasc Disord 2007;7:3 (online).
19. Leng GC and Fowkes FG: The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101-1109.
20. Krantz MJ, Coronel SM, and Hiatt WR: Use of ankle brachial index screening for selecting patients for antiplatelet drug therapy. Pharmacotherapy 2005;25:1826-1828.
21. Olijhoek JK, van der Graaf Y, Banga JD, et al.: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004;25:342-348.
22. Lahoz C, Vicente I, Laguna F, et al.: Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care 2006;29:148-150.
23. Tapp RJ, Balkau B, Shaw JE, et al., on behalf of the DESIR study group: Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis 2007;190:84-89.
24. Murabito JM, Evans JC, Nieto K, et al.: Prevalence and clinical correlates of peripheral artery disease in the Framingham Offspring Study. Am Heart J 2002;143:961-965.
25. Girman CJ, Rhodes T, Mercuri M, et al.: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136-141.
26. Vicente I, Lahoz C, Taboada M, et al.: Prevalence of abnormal ankle-brachial index in relation to the cardiovascular risk estimated by the Framingham function. Med Clin (Barc) 2005;124:641-644.
27. Periard D, Cavassini M, Taffé P, et al.: High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis 2008;46:761-767.
28. Bernal E, Masiá M, Padilla S, Hernández I, and Gutiérrez F: Low prevalence of peripheral arterial disease in HIV-infected patients with multiple cardiovascular risk factors. J Acquir Immune Defic Syndr 2008;47:126-127.